Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SRN001 in Healthy Korean and Caucasian Adult Males [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of SRN001 in healthy Korean and Caucasian adult males; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• SRN001

Snippet

Sponsor: siRNAgen Therapeutics Inc. | Conditions: Idiopathic Pulmonary Fibrosis | Phase 1 | Status: RECRUITING